The self-monitoring blood-glucose devices and strips market in Taiwan is estimated to be worth $86m by 2016, according to an analysis from Frost & Sullivan.

The reports says that the market, worth $32.5m in 2009, is being fuelled by the increased incidence of diabetes in the country.

Over the past five years, the retail sales of blood glucose metres and strips used in the self-monitoring of diabetes have increased exponentially, bringing in significant revenue for the manufacturers.

However, a lack of awareness about the symptoms of diabetes in the rural and suburban areas is restraining the market.

The analysis also predicts that the introduction of biosensor technology may eventually replace strips.